Cargando…
MEF2D在肺腺癌中的表达及与预后的相关性分析
Background and objective Myocyte enhancer factor 2D (MEF2D) can participate in the process of tumor lesions by regulating the transcription of oncogenes. In a previous study, MEF2D was demonstrated to enhance the proliferation and metastasis of lung adenocarcinoma cells A549 and H1299 by promoting t...
Autores principales: | YE, Guangbin, ZHANG, Zhongwei, LI, Yanli, GAO, Li, HUANG, Wei, LING, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476217/ https://www.ncbi.nlm.nih.gov/pubmed/37653017 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.25 |
Ejemplares similares
-
ASPM在肺腺癌中的表达及其与肺腺癌的进展和预后关系的研究
Publicado: (2020) -
MiR-148b-3p在肺腺癌中的表达及其与患者预后的相关性
Publicado: (2019) -
多种肿瘤标志物在肺腺癌中的表达及预后意义的研究
Publicado: (2014) -
肺腺癌组织中OCT4表达与患者临床指标及预后的相关性
Publicado: (2013) -
OLC1在肺鳞癌组织中的过表达与患者的不良预后相关
Publicado: (2017)